We showed that there are no differences in C3 complement levels according to CRP stratification, but SLE patients with average and high CVD risk by CRP levels (≥1 mg/L) tended to have lower C4 complement levels than patients with low CRP levels (<1 mg/L). The gene discussed is C3; the disease is systemic lupus erythematosus.